Low-energy Shock Wave Therapy-A Novel Treatment Option for Erectile Dysfunction in Men With Cardiovascular Disease

Dariusz Kałka1, Jana Gebala2, Ryszard Smoliński3

  • 1Cardiosexology Unit, Department of Pathophysiology, Wrocław Medical University, Wrocław, Poland; Centre for Men's Health, Wrocław, Poland.

Urology
|June 3, 2017
PubMed

Insights

Low-energy shock wave therapy shows promise for treating erectile dysfunction (ED) in men with cardiovascular disease (CVD). This novel approach may offer a causative treatment option for ED, addressing a common comorbidity in CVD patients.

Area of Science:

  • Cardiovascular Medicine
  • Urology
  • Regenerative Medicine

Background:

  • Cardiovascular disease (CVD) and erectile dysfunction (ED) share common risk factors and underlying pathologies.
  • ED affects a significant majority (nearly 80%) of male patients diagnosed with CVD.
  • Existing ED treatments like PDE5 inhibitors have limitations in this patient population.

Purpose of the Study:

  • To review the efficacy of low-energy shock wave therapy (Li-ESWT) for treating ED in men with CVD.
  • To evaluate the safety profile of Li-ESWT in this specific patient group.
  • To explore Li-ESWT as a potential causative treatment for ED.

Main Methods:

  • Systematic review of existing literature on low-energy shock wave therapy for ED.
  • Analysis of studies focusing on male patients with comorbid CVD.
  • Assessment of reported efficacy and safety data from clinical trials.

Main Results:

  • Low-energy shock wave therapy demonstrates potential efficacy in improving erectile function in men with CVD.
  • The safety profile of Li-ESWT appears favorable in the reviewed studies.
  • Li-ESWT may offer a novel therapeutic avenue beyond conventional ED treatments.

Conclusions:

  • Low-energy shock wave therapy is a promising, potentially causative treatment for ED in men with cardiovascular disease.
  • Further research is warranted to establish optimal protocols and long-term outcomes.
  • Li-ESWT represents a significant advancement in managing ED in the context of CVD.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
671
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.3K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
445
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.6K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
24.1K